Experience

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2023 issued by Export Development Canada. Export…

We favorably resolved four separate ICC arbitrations for our client

Davis Polk is advising Kyocera Corporation in connection with its proposed acquisition of the shares of common stock of AVX Corporation not already owned by Kyocera for $21.75 per share or…

Davis Polk is advising an ad hoc group of lenders under VIP Cinema Holding, Inc.’s first-lien term loan facility and first-lien revolving credit facility in the chapter 11 restructuring of…

Davis Polk advised Comcast Corporation on its SEC-registered debt offering of €800 million aggregate principal amount of its 0.250% notes due 2027, €1.4 billion aggregate principal amount…

Davis Polk advised the joint lead managers in connection with the Regulation S offering of $110 million principal amount of 12.5% senior notes due 2022 by Yango (Cayman) Investment Limited…

Davis Polk advised the underwriters in connection with a primary offering of 41,431,635 ordinary shares in Gold Fields Limited at a price of ZAR 90.20 per placing share. Gold Fields…

Davis Polk is advising Morgan Stanley on its $13 billion acquisition of E*TRADE Financial Corporation. The transaction is expected to close in the fourth quarter of 2020, subject to…

We are advising L Brands on the separation of Victoria’s Secret